176 related articles for article (PubMed ID: 27073039)
1. Treatment of Acute Myeloid Leukemia in Elderly Patients-A Therapeutic Dilemma.
Mamdani H; Santos CD; Konig H
J Am Med Dir Assoc; 2016 Jul; 17(7):581-7. PubMed ID: 27073039
[TBL] [Abstract][Full Text] [Related]
2. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
3. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
4. Treating acute myeloid leukemia in older adults.
Wang ES
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):14-20. PubMed ID: 25696830
[TBL] [Abstract][Full Text] [Related]
5. High response rate for treatment with gemtuzumab ozogamicin and cytarabine in elderly patients with acute myeloid leukemia and favorable and intermediate-I cytogenetic risk.
Tavor S; Rahamim E; Sarid N; Rozovski U; Gibstein L; Aviv F; Kirsner I; Naparstek E
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):438-43. PubMed ID: 23017331
[TBL] [Abstract][Full Text] [Related]
6. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.
Oh SB; Park SW; Chung JS; Lee WS; Lee HS; Cho SH; Choi YS; Lim SN; Shin HJ;
Ann Hematol; 2017 Nov; 96(11):1801-1809. PubMed ID: 28828639
[TBL] [Abstract][Full Text] [Related]
9. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
[TBL] [Abstract][Full Text] [Related]
10. Therapy of older persons with acute myeloid leukaemia.
Krug U; Gale RP; Berdel WE; Müller-Tidow C; Stelljes M; Metzeler K; Sauerland MC; Hiddemann W; Büchner T
Leuk Res; 2017 Sep; 60():1-10. PubMed ID: 28618329
[TBL] [Abstract][Full Text] [Related]
11. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.
Kuendgen A; Germing U
Cancer Treat Rev; 2009 Apr; 35(2):97-120. PubMed ID: 18951721
[TBL] [Abstract][Full Text] [Related]
12. Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction.
Rao AV
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):339-347. PubMed ID: 27913500
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of elderly patients with acute myeloid leukemia].
Nakazato T
Rinsho Ketsueki; 2017; 58(10):1905-1912. PubMed ID: 28978831
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of efficacy and prognosis of induction chemotherapy in 76 elderly patients with acute myeloid leukemia (non-APL)].
Yang H; Niu JH; Zhu CY; Zhang Q; Zhu HY; Yao ZL; Zhou MH; Wang QS; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):957-64. PubMed ID: 25130810
[TBL] [Abstract][Full Text] [Related]
15. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.
Isidori A; Venditti A; Maurillo L; Buccisano F; Loscocco F; Manduzio P; Sparaventi G; Amadori S; Visani G
Expert Rev Hematol; 2013 Dec; 6(6):767-84. PubMed ID: 24219553
[TBL] [Abstract][Full Text] [Related]
16. Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
Seymour JF; Döhner H; Butrym A; Wierzbowska A; Selleslag D; Jang JH; Kumar R; Cavenagh J; Schuh AC; Candoni A; Récher C; Sandhu I; Del Castillo TB; Al-Ali HK; Falantes J; Stone RM; Minden MD; Weaver J; Songer S; Beach CL; Dombret H
BMC Cancer; 2017 Dec; 17(1):852. PubMed ID: 29241450
[TBL] [Abstract][Full Text] [Related]
17. Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia.
Fattoum J; Cannas G; Elhamri M; Tigaud I; Plesa A; Heiblig M; Plesa C; Wattel E; Thomas X
Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):477-83. PubMed ID: 25843415
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
Malfuson JV; Etienne A; Turlure P; de Revel T; Thomas X; Contentin N; Terré C; Rigaudeau S; Bordessoule D; Vey N; Gardin C; Dombret H;
Haematologica; 2008 Dec; 93(12):1806-13. PubMed ID: 18838471
[TBL] [Abstract][Full Text] [Related]
19. Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?
Thomas X; Chelghoum Y; Cannas G; Elhamri M; Labussière H; Tigaud I; Ducastelle S; Nicolini F; Dumontet C; Michallet M
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):342-9. PubMed ID: 21816372
[TBL] [Abstract][Full Text] [Related]
20. Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.
Lim MY; Jamieson K
Clin Interv Aging; 2014; 9():753-62. PubMed ID: 24851045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]